In studies, semaglutide caused these tumors in rodents
as dose climbs, GLP-1 satiety and glucagon heart-rate / liver-fat effects become more relevant
The evidence gap between supplement-class compounds and pharmaceutical-grade GLP-1 medications is substantial in both quantity and rigor
Kraft, M., Kraft, K., Grtner, S., Mayerle, J., Simon, P., Weber, E., Schtte, K., Stieler, J., Koula-Jenik, H., Holzhauer, P., Grber, U., Engel, G., Mller, C., Feng, Y.-S., Aghdassi, A., Nitsche, C., Malfertheiner, P., Patrzyk, M., Kohlmann, T., & Lerch, M
Some of the restaurants will be able to just pivot their marketing and show that it fits within your diet, versus having to engineer a menu to target [GLP-1] consumers, Haracz said